Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies

CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …

Bone microenvironment signals in osteosarcoma development

A Alfranca, L Martinez-Cruzado, J Tornin… - Cellular and Molecular …, 2015 - Springer
The bone is a complex connective tissue composed of many different cell types such as
osteoblasts, osteoclasts, chondrocytes, mesenchymal stem/progenitor cells, hematopoietic …

Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma

Z Yang, X Li, Y Yang, Z He, X Qu, Y Zhang - Cell death & disease, 2016 - nature.com
Long noncoding RNAs (lncRNAs) are a class of non-protein-coding molecules longer than
200 nucleotides that are involved in the development and progression of many types of …

Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy

K Yan, Q Wu, DH Yan, CH Lee, N Rahim… - Genes & …, 2014 - genesdev.cshlp.org
Glioblastomas are the most prevalent and lethal primary brain tumor and are comprised of
hierarchies with self-renewing cancer stem cells (CSCs) at the apex. Like neural stem cells …

[HTML][HTML] Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets

GN Yan, YF Lv, QN Guo - Cancer letters, 2016 - Elsevier
Osteosarcoma is the most common type of bone cancer, especially in children and young
adults. The primary treatment for osteosarcoma is a combination of surgery and …

ACVR1 function in health and disease

JA Valer, C Sánchez-de-Diego, C Pimenta-Lopes… - Cells, 2019 - mdpi.com
Activin A receptor type I (ACVR1) encodes for a bone morphogenetic protein type I receptor
of the TGFβ receptor superfamily. It is involved in a wide variety of biological processes …

Integrated Analysis of Transcriptome-Wide m6A Methylome of Osteosarcoma Stem Cells Enriched by Chemotherapy

Y Wang, L Zeng, C Liang, R Zan, W Ji, Z Zhang… - …, 2019 - Taylor & Francis
Aim: To analyze the m6A methylome of osteosarcoma stem cells (OSCs). Materials &
methods: Chemoresistant OSCs were enriched by doxorubicin treatment. Expression of m6A …

BMP-2 induces EMT and breast cancer stemness through Rb and CD44

P Huang, A Chen, W He, Z Li, G Zhang, Z Liu… - Cell death …, 2017 - nature.com
Abstract Bone morphogenetic protein 2 (BMP-2) has been reported to facilitate epithelial-to-
mesenchymal transition (EMT) and bone metastasis in breast cancer xenograft models. To …

[HTML][HTML] BMP signaling and its paradoxical effects in tumorigenesis and dissemination

L Zhang, Y Ye, X Long, P Xiao, X Ren, J Yu - Oncotarget, 2016 - ncbi.nlm.nih.gov
Bone morphogenetic proteins (BMPs) play important roles in embryonic and postnatal
development by regulating cell differentiation, proliferation, motility, and survival, thus …

The role of tumor microenvironment in regulating the plasticity of osteosarcoma cells

B Tian, X Du, S Zheng, Y Zhang - International Journal of Molecular …, 2022 - mdpi.com
Osteosarcoma (OS) is a malignancy that is becoming increasingly common in adolescents.
OS stem cells (OSCs) form a dynamic subset of OS cells that are responsible for malignant …